Patent US5132223A successfully refreshed from Google Patents.
US5132223A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process and medium for cloning and long-term serial cultivation of adult human endothelial cells
Assignee: Thomas Jefferson University
•
Filing: 1990-11-05
•
Granted: 1992-07-21
•
Expires: 2010-11-05
Abstract
Abstract Vigorous growth of endothelial cells from human blood vessels in vitro is achieved using a culture medium containing endothelial cell growth factor and heparin and/or dextran sulfate. Cell population doubling times of 13 to 21 hours for 60 to 85 populations doublings are obtained, and cloned human endothelial cell strains are established having similar proliferative capacities.
Inventors
- 👤 Elliot M. Levine
- 👤 Sandor S. Shapiro
- 👤 Bruce E. Jarrell
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 16:00
CPC Classifications
C; C12; C12N; C12N5/00; C12N5/06; C12N5/0602; C12N5/069; C12N2501/00; C12N2501/90; C12N2501/91
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
56 words
A process for enhancing proliferation and increasing the lifespan of adult vessel human endothelial cell cultures which comprises culturing adult vessel human endothelial cells in the presence of a cell culture medium containing effective amounts of endothelial cell growth factor (ECGF) and a material selected from the group consisting of heparin, dextran sulfate, and mixtures thereof.
Claim 2
Dependent Claim
56 words
A process for enhancing proliferation and increasing the lifespan of adult vessel human endothelial cell cultures which comprises culturing adult vessel human endothelial cells in the presence of a cell culture medium containing effective amounts of endothelial cell growth factor (ECGF) and a material selected from the group consisting of heparin, dextran sulfate, and mixtures thereof.
Claim 3
Dependent Claim
50 words
The process of claim 1 in which said endothelial cell culture medium comprises from about 5 to about 30% fetal bovine serum and from about 70 to about 95% of a cell culture medium, said percentages being by volume based on the total volume of said endothelial cell culture medium.
Claim 4
Dependent Claim
34 words
The process according to claim 2 in which said culture medium contains from about 10 to about 200 μg/ml of endothelial cell growth factor and from about 9 to about 900 μg/ml of heparin.
Claim 5
Dependent Claim
31 words
The process of claim 3 in which said culture medium comprises about 20% fetal bovine serum and contains about 20 μg/ml of endothelial cell growth factor and about 90 μg/ml heparin.
Claim 6
Dependent Claim
34 words
The process of claim 2 in which said culture medium contains from about 10 to about 200 μg/ml of endothelial cell growth factor and from about 5 to about 500 μg/ml of dextran sulfate.
Claim 7
Dependent Claim
24 words
the process of claim 5 in which said culture medium comprises about 20% fetal calf serum, and contains about 100 μg/ml of dextran sulfate.
Claim 8
Dependent Claim
54 words
The process of claim 1 in which said cell culture is trypsinized when a cell density of at least about 6×10 4 /cm 2 is obtained, subcultures are reseeded at predetermined densities from said trypsinized cultures, clones are derived from said secondary cultures, and said clones are serially propagated in said cell culture medium.
Claim 9
Dependent Claim
24 words
The process of claim 1 in which said endothelial cells are derived from adult human vascular tissue obtained from a brain-dead, heart-beating cadaver donor.
Claim 10
Dependent Claim
45 words
The process according to claim 8 in which said cadaver donor is given from about 10,000 to about 20,000 units intravenous aqueous heparin and from about 5 to about 15 mg of phenoxybenzamine prior to dissection and removal of said vascular tissue from said cadaver.
Claim 11
Dependent Claim
36 words
The process according to claim 9 in which said cadaver donor is given about 15,000 units intavenous aqueous heparin and about 10 mg phenoxybenzamine prior to dissection and removal of said vascular tissue from said cadaver.
Claim 12
Dependent Claim
48 words
The process according to claim 8 in which said vascular tissue is placed immediately after being obtained in an endothelial growth medium comprising about 20% fetal bovine serum, about 80% cell culture medium and containing about 20 μg/ml of endothelial cell growth factor and about 90 μg/ml heparin.
References Cited (Backward Citations)
US4994387A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-07-21 | 1996-01-20 | 1996-07-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-07-21 | 2000-01-20 | 2000-07-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-07-21 | 2004-01-20 | 2004-07-21 | $7700.00 | Window Closed / Lapsed |